InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by O'Brien Anthony Stephen, Director. Director active across 2 companies, notably Evofem Biosciences, Inc.. Cumulatively, 2 filings have been recorded. Total volume traded: €18k. The latest transaction was filed on 14 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€8,7978,140 shares@ €1.08071.02% mcap100.0% of flow
Common Stock
SEC:0001618835-21-000153·
Ideal exit: 11 Mar 2022 (T+270)
€8,7978,140 shares@ €1.08071.02% mcap50.0% of flow
Common Stock
SEC:0001618835-21-000153:0·
Ideal exit: 11 Mar 2022 (T+270)
2 of 2 declarations
About O'Brien Anthony Stephen
Anthony Stephen O'Brien is a Board Member at Evofem Biosciences, Inc. He plays an important role in the governance of the company, bringing his expertise in the life sciences field. As a board member, Anthony Stephen O'Brien contributes to the formulation of strategies that promote innovation and growth. His industry experience enables him to guide the company through regulatory and commercial challenges.
